Axon Enterprise (AXON) Valuation Check After Strong Q1 2026 Beat And Raised Revenue Outlook

Axovant Sciences Ltd

Axovant Sciences Ltd

AXON

0.00

Axon Enterprise (AXON) is back in focus after its Q1 2026 report, which beat analyst expectations, came with higher full-year revenue guidance, and highlighted strong momentum in connected devices and AI-driven public safety tools.

Despite the strong Q1 earnings beat and the raised 2026 revenue outlook, Axon’s share price is down 30.37% year to date and its 1 year total shareholder return is down 47.18%. However, the 3 year total shareholder return of 100.38% and 5 year total shareholder return of 200.11% still point to substantial longer term gains.

If Axon’s recent volatility has you thinking about where else AI linked growth could come from, this is a good moment to size up 63 profitable AI stocks that aren't just burning cash

So with Axon’s stock sharply lower this year despite rising guidance and strong AI and device momentum, should you see today’s valuation as a reset that leaves upside on the table, or is the market already factoring in years of growth?

Most Popular Narrative: 35.3% Undervalued

Axon’s most followed narrative pegs fair value at $606.83 per share, well above the last close at $392.34. That raises an obvious question about what is driving that gap.

One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.

According to AryaWinningSon, this valuation leans heavily on Axon’s shift toward recurring software revenue, expectations around margin uplift, and an earnings profile that looks very different from a pure hardware supplier. It is worth examining which growth and profitability assumptions sit underneath that $606.83 fair value and how they connect to Axon’s public safety ecosystem.

Result: Fair Value of $606.83 (UNDERVALUED)

However, this hinges on Axon sustaining its software momentum and keeping public sector customers locked in. Any slowdown in contract wins or pricing power could quickly challenge that view.

Another View: Pricing Power Cuts Both Ways

That 35.3% undervalued narrative sits beside a very different signal from Axon’s pricing. The stock trades on a P/S of 10.6x, compared with 5x for the US Aerospace & Defense industry and a fair ratio of 14.4x. That premium suggests investors are already paying up for growth, so the key question is how much room is left if sentiment turns again.

NasdaqGS:AXON P/S Ratio as at May 2026
NasdaqGS:AXON P/S Ratio as at May 2026

Next Steps

If this mix of optimism and concern around Axon feels familiar, do not wait for consensus to form. Instead, weigh the 1 key reward and 3 important warning signs

Looking for more investment ideas?

If you are serious about building a stronger portfolio, this is the moment to cast the net wider and see what else the market is offering.

Use the Simply Wall Street Screener to uncover ideas other investors may be missing before the next shift in sentiment.

  • Target resilient cash generators by reviewing the solid balance sheet and fundamentals stocks screener (46 results) that can help anchor your portfolio when growth stories get choppy.
  • Hunt for mispriced opportunities by scanning the 54 high quality undervalued stocks that combine quality fundamentals with potential upside the market may not be pricing in.
  • Prioritize stability with yield by focusing on the 12 dividend fortresses that could help you build a steadier income stream alongside your growth holdings.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.